58 results
8-K
EX-99.5
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
stock for a total purchase price of $242. The founders’ shares were issued under the Company’s equity incentive plan, have the same voting rights … by the founders were fully vested upon issuance.
Equity Incentive Plan and Stock-Based Compensation
Equity Incentive Plan
In November, the Company’s Board
8-K
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
, the Board granted to Dr. Thomas 200,750 restricted stock units (“RSUs”), pursuant to the Company’s 2021 Equity Incentive Plan. Of the RSUs granted to Dr
8-K
EX-99.4
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
. The founders’ shares were issued out of the Company’s equity incentive plan, have the same voting rights as other common stock, and are entitled … .
Equity Incentive Plan and Stock-Based Compensation
Equity Incentive Plan
In November, the Company’s Board of Directors adopted, and its stockholders
DEFA14A
ELYM
Eliem Therapeutics Inc
12 Jun 24
Additional proxy soliciting materials
4:42pm
as of the Effective Date, the Eliem Board approved the grant to Dr. Brennan of (i) an incentive stock option to purchase 550,000 shares of Eliem common stock … (the “Option”) and (ii) 275,000 restricted stock units (“RSUs”). The Option and the RSUs will be granted pursuant to Eliem’s 2021 Equity Incentive Plan
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
(the “Option”). The Option will be an incentive stock option to the fullest extent permitted under the Internal Revenue Code of 1986, as amended (the “Code … ”). The Option, will be governed by the terms and conditions of the Company’s 2021 Equity Incentive Plan (the “Plan”) and a grant agreement issued
8-K
1kul7er3vowmj5
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
DEFM14A
e34b1m
4 Jun 24
Proxy related to merger
8:00am
PREM14A
9suplzi8e yo
17 May 24
Preliminary proxy related to merger
4:36pm
DEFA14A
cb1awp
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-2.1
nc8fbus8002io
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
S-8
1si81 re0gm
28 Mar 24
Registration of securities for employees
4:27pm
S-8
vxzs1a trb6xavkm61
28 Mar 24
Registration of securities for employees
4:27pm
S-8
EX-5.1
25wc8 15r0vel9a
28 Mar 24
Registration of securities for employees
4:27pm